Activation of the TLR4-myD88-NFκB signaling pathway, an important pathway associated with hepatic fibrosis and HCC, can lead to the release of downstream inflammatory factors and induce the production of IL-1, IL-6, and TNF-α. This evidence concerns the gene IL6 and Hepatic fibrosis.